文献速递关节外科创伤骨科

阿司匹林用于有胃肠道病史患者全关节置换术后静脉血栓预防的安全性

Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues.
PubMed 文献 · J Arthroplasty · 2021-01-30

这项机构回顾性队列研究纳入19,044例2013至2019年行初次全髋或全膝关节置换的患者,按有无术前胃肠道问题分组。结果显示,在接受阿司匹林的患者中,有无术前胃肠道问题者的术后消化道出血率无显著差异(0.11% vs 0.10%,P=1.0);

要点

  • 有胃肠道病史患者使用阿司匹林预防VTE,术后消化道出血率与无病史者无显著差异。
  • 阿司匹林是本研究中最常用的VTE预防方式,占89%。
  • 多因素分析中阿司匹林与消化道出血风险降低相关(OR=0.09)。

核心结论

  • 对于有胃肠道问题病史的患者,全关节置换术后使用阿司匹林进行VTE预防是安全的,不增加术后消化道出血风险。

研究设计与样本

  • 机构回顾性队列研究,纳入2013至2019年行初次全髋和全膝关节置换的19,044例患者,按有无术前胃肠道问题分为两组。

主要发现

  • 3,090例患者有术前胃肠道问题,15,954例无胃肠道问题。
  • 在接受阿司匹林的患者中,有术前胃肠道问题者术后消化道出血2/1,781(0.11%),无胃肠道问题者8/7,628(0.10%),差异无统计学意义(P=1.0)。

关键数值与推荐

  • VTE预防方式分布:阿司匹林89%,华法林4.7%,直接口服抗凝药4.2%,低分子肝素1.7%,其他0.4%。

临床怎么用

  • 对于有胃肠道问题病史的全关节置换患者,可考虑使用阿司匹林进行VTE预防,但需结合总体队列中胃肠道病史与出血风险增加的相关性进行个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety of acetylsalicylic acid (ASA, aspirin) in patients with prior history of gastroesophageal reflux or peptic ulcer disease remains unclear. The purpose of this study was to determine the safety of ASA for venous thromboembolism (VTE) prophylaxis after total joint arthroplasty in patients with prior history of gastrointestinal (GI) issues. METHODS: This was an institutional, retrospective cohort study of 19,044 patients who underwent primary total hip and total knee arthroplasty from 2013 to 2019. We divided the patients into two cohorts based on the presence or absence of pre-existing GI issues. Patient demographics, VTE prophylaxis, and postoperative complications were collected. The primary outcome measure was GI bleed. RESULTS: In our series, 3090 patients had a preoperative GI issue and 15,954 did not have a GI issue. ASA was the most common mode of VTE prophylaxis (89%), followed by Coumadin (4.7%), direct oralanticoagulants (4.2%), low-molecular-weight heparin (1.7%), and others (0.4%). In the cohort of patients given ASA, there was no significant difference in postoperative GI bleeding between those with (2/1781, 0.11%) and without preoperative GI issues (8/7,628, 0.10%, P = 1.0). In the overall cohort, history of preoperative GI issues was associated with an increased risk of postoperative GI bleeding (0.32% vs 0.11%, P = .031). In logistic regression analysis, ASA was associated with a protective effect against GI bleed (OR = 0.09, 95% CI 0.01-0.40, P = .003). CONCLUSION: ASA is safe for VTE prophylaxis after total joint arthroplasty in patients with history of GI issues and is not associated with an increased risk of postoperative GI bleeds.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Grosso MJ, Kozaily E, Parvizi J, et al. Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues. J Arthroplasty. 2021. PMID: 33610409. doi:10.1016/j.arth.2021.01.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。